Viewing Study NCT01707069


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT01707069
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2012-10-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
Sponsor: Immunomic Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module